FDA clears Bioject's needle-free injection system for Serostim:
This article was originally published in Clinica
Executive Summary
Bioject Medical Technologies' needle-free delivery device, SeroJet, was customised and tested for exclusive use with Serono's recombinant human growth hormone, Serostim, which is used to treat AIDS wasting or cachexia. Serono is the only firm to provide a needle-free delivery system for Serostim in the US, claims Bioject, of Portland, Oregon.